title: Intraventricular administration of teicoplanin in shunt associated ventriculitis caused by methicillin resistant Staphylococcus aureus.
authors.forename: M
authors.initials: M
authors.lastname: Venditti
authors.forename: A
authors.initials: A
authors.lastname: Micozzi
authors.forename: P
authors.initials: P
authors.lastname: Serra
authors.forename: G
authors.initials: G
authors.lastname: Buniva
authors.forename: L
authors.initials: L
authors.lastname: Palma
authors.forename: P
authors.initials: P
authors.lastname: Martino
mesh_terms: D000328:Adult; D002552:Cerebral Ventricles; D002557:Cerebrospinal Fluid Shunts / Q000009:adverse effects*; D002648:Child; D004660:Encephalitis / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006020:Glycopeptides / Q000008:administration & dosage; D006801:Humans; D007276:Injections, Intraventricular; D008297:Male; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000209:etiology; D017334:Teicoplanin
chemical_list: D006020:Glycopeptides; D017334:Teicoplanin